{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:47:22Z","timestamp":1790063242340,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jacbts.2025.101449","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T22:28:54Z","timestamp":1766183334000},"page":"101449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Myosin Modulator Aficamten Inhibits Force by Altering Myosin\u2019s Biochemical Activity Without Changing Thick Filament Structure"],"prefix":"10.1016","volume":"11","author":[{"given":"Saffie","family":"Mohran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina B.","family":"Kooiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ateeqa","family":"Naim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matvey","family":"Pilagov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Asencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyrah L.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weikang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Flint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy S.","family":"McMillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mandrycky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Mahoney-Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Irving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand C.W.","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil M.","family":"Kad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Regnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0189-7214","authenticated-orcid":false,"given":"Farid","family":"Moussavi-Harami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.jacbts.2025.101449_bib1","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.jacc.2024.02.014","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Ommen","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2025.101449_bib2","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1093\/eurheartj\/ehae421","article-title":"Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice","volume":"45","author":"Lopes","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2025.101449_bib3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacbts.2025.101449_bib4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.7326\/M18-3016","article-title":"Mavacamten treatment for obstructive hypertrophic cardiomyopathy: a clinical trial","volume":"170","author":"Heitner","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacbts.2025.101449_bib5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","author":"Green","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jacbts.2025.101449_bib6","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1080\/00498254.2018.1495856","article-title":"In vitro and in vivo pharmacokinetic characterization of mavacamten, a first-in-class small molecule allosteric modulator of beta cardiac myosin","volume":"49","author":"Grillo","year":"2019","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jacbts.2025.101449_bib7","doi-asserted-by":"crossref","first-page":"E8143","DOI":"10.1073\/pnas.1809540115","article-title":"Deciphering the super relaxed state of human beta-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers","volume":"115","author":"Anderson","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2025.101449_bib8","doi-asserted-by":"crossref","first-page":"E7486","DOI":"10.1073\/pnas.1720342115","article-title":"Mavacamten stabilizes an autoinhibited state of two-headed cardiac myosin","volume":"115","author":"Rohde","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"10.1016\/j.jacbts.2025.101449_bib9","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1111\/bph.15271","article-title":"Effects of mavacamten on Ca(2+) sensitivity of contraction as sarcomere length varied in human myocardium","volume":"177","author":"Awinda","year":"2020","journal-title":"Br J Pharmacol"},{"issue":"7","key":"10.1016\/j.jacbts.2025.101449_bib10","doi-asserted-by":"crossref","DOI":"10.1085\/jgp.202012789","article-title":"Mavacamten has a differential impact on force generation in myofibrils from rabbit psoas and human cardiac muscle","volume":"153","author":"Scellini","year":"2021","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.jacbts.2025.101449_bib11","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJMoa2401424","article-title":"Aficamten for symptomatic obstructive hypertrophic cardiomyopathy","volume":"390","author":"Maron","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacbts.2025.101449_bib12","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s44161-024-00505-0","article-title":"Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy","volume":"3","author":"Hartman","year":"2024","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2025.101449_bib13","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.molcel.2010.02.003","article-title":"Collaborative dynamic DNA scanning by nucleotide excision repair proteins investigated by single- molecule imaging of quantum-dot-labeled proteins","volume":"37","author":"Kad","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.jacbts.2025.101449_bib14","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1074\/jbc.M114.609743","article-title":"Using fluorescent myosin to directly visualize cooperative activation of thin filaments","volume":"290","author":"Desai","year":"2015","journal-title":"J Bio Chem"},{"key":"10.1016\/j.jacbts.2025.101449_bib15","doi-asserted-by":"crossref","DOI":"10.1007\/s10974-025-09712-z","article-title":"Direct measurement of mavacamten and deoxyATP perturbation of the SRX\/DRX ratio in porcine cardiac myofibrils using a simple, accessible and multiplexed approach","author":"Pilagov","year":"2025","journal-title":"J Muscle Res Cell Motil"},{"key":"10.1016\/j.jacbts.2025.101449_bib16","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCRESAHA.123.322629","article-title":"Danicamtiv increases myosin recruitment and alters cross-bridge cycling in cardiac muscle","volume":"133","author":"Kooiker","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2025.101449_bib17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1107\/S0909049504016760","article-title":"The BioCAT undulator beamline 18ID: a facility for biological non-crystalline diffraction and X-ray absorption spectroscopy at the Advanced Photon Source","volume":"11","author":"Fischetti","year":"2004","journal-title":"J Synchrotron Radiat"},{"key":"10.1016\/j.jacbts.2025.101449_bib18","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.bpj.2018.08.038","article-title":"Thick-filament extensibility in intact skeletal muscle","volume":"115","author":"Ma","year":"2018","journal-title":"Biophys J"},{"key":"10.1016\/j.jacbts.2025.101449_bib19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCRESAHA.120.318647","article-title":"The super-relaxed state and length dependent activation in porcine myocardium","volume":"129","author":"Ma","year":"2021","journal-title":"Circ Res"},{"issue":"20","key":"10.1016\/j.jacbts.2025.101449_bib20","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142446","article-title":"Modulating the tension-time integral of the cardiac twitch prevents dilated cardiomyopathy in murine hearts","volume":"5","author":"Powers","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jacbts.2025.101449_bib21","doi-asserted-by":"crossref","first-page":"H2087","DOI":"10.1152\/ajpheart.00555.2015","article-title":"Myosin MgADP release rate decreases at longer sarcomere length to prolong myosin attachment time in skinned rat myocardium","volume":"309","author":"Tanner","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"10.1016\/j.jacbts.2025.101449_bib22","doi-asserted-by":"crossref","DOI":"10.1085\/jgp.202213250","article-title":"RLC phosphorylation amplifies Ca2+ sensitivity of force in myocardium from cMyBP-C knockout mice","volume":"155","author":"Turner","year":"2023","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.jacbts.2025.101449_bib23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1161\/hh0102.103221","article-title":"Alterations of myocardial dynamic stiffness implicating abnormal crossbridge function in human mitral regurgitation heart failure","volume":"90","author":"Mulieri","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2025.101449_bib24","doi-asserted-by":"crossref","first-page":"H1535","DOI":"10.1152\/ajpheart.01029.2003","article-title":"Interpreting cardiac muscle force-length dynamics using a novel functional model","volume":"286","author":"Campbell","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2025.101449_bib25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1113\/JP271290","article-title":"Contractile properties of developing human fetal cardiac muscle","volume":"594","author":"Racca","year":"2016","journal-title":"J Physiol"},{"key":"10.1016\/j.jacbts.2025.101449_bib26","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.yjmcc.2014.12.002","article-title":"2-Deoxy adenosine triphosphate improves contraction in human end-stage heart failure","volume":"79","author":"Moussavi-Harami","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2025.101449_bib27","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jacbts.2018.08.008","article-title":"Novel adult-onset systolic cardiomyopathy due to MYH7 E848G mutation in patient-derived induced pluripotent stem cells","volume":"3","author":"Yang","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jacbts.2025.101449_bib28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.yjmcc.2018.03.016","article-title":"Afterload promotes maturation of human induced pluripotent stem cell derived cardiomyocytes in engineered heart tissues","volume":"118","author":"Leonard","year":"2018","journal-title":"J Mol Cell Cardiol"},{"issue":"8","key":"10.1016\/j.jacbts.2025.101449_bib29","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s44161-024-00505-0","article-title":"aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy","volume":"3","author":"Hartman","year":"2024","journal-title":"Nat Cardiovasc Res"},{"issue":"Pt 3","key":"10.1016\/j.jacbts.2025.101449_bib30","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1469-7793.1999.0847u.x","article-title":"Modulation by substrate concentration of maximal shortening velocity and isometric force in single myofibrils from frog and rabbit fast skeletal muscle","volume":"516","author":"Tesi","year":"1999","journal-title":"J Physiol"},{"key":"10.1016\/j.jacbts.2025.101449_bib31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00424-008-0630-2","article-title":"Insights into the kinetics of Ca2+-regulated contraction and relaxation from myofibril studies","volume":"458","author":"Stehle","year":"2009","journal-title":"Pfl\u00fcgers Archiv \u2013 Eur J Physiol"},{"key":"10.1016\/j.jacbts.2025.101449_bib32","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.cell.2016.04.002","article-title":"A tension-based model distinguishes hypertrophic versus dilated cardiomyopathy","volume":"165","author":"Davis","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jacbts.2025.101449_bib33","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.jacc.2024.08.015","article-title":"Effect of aficamten on cardiac structure and function in obstructive hypertrophic cardiomyopathy: SEQUOIA-HCM CMR Substudy","volume":"84","author":"Masri","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2025.101449_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105565","article-title":"The biochemically defined super relaxed state of myosin\u2014a paradox","volume":"300","author":"Mohran","year":"2024","journal-title":"J Bio Chem"},{"key":"10.1016\/j.jacbts.2025.101449_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgae039","article-title":"The structural OFF and ON states of myosin can be decoupled from the biochemical super- and disordered-relaxed states","volume":"3","author":"Jani","year":"2024","journal-title":"PNAS Nexus"},{"issue":"1","key":"10.1016\/j.jacbts.2025.101449_bib36","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1038\/s41467-024-47587-9","article-title":"Omecamtiv mecarbil and mavacamten target the same myosin pocket despite opposite effects in heart contraction","volume":"15","author":"Auguin","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacbts.2025.101449_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167295","article-title":"Two classes of myosin inhibitors, para-nitroblebbistatin and mavacamten, stabilize beta-cardiac myosin in different structural and functional states","volume":"433","author":"Gollapudi","year":"2021","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jacbts.2025.101449_bib38","doi-asserted-by":"crossref","first-page":"35557","DOI":"10.1074\/jbc.M405319200","article-title":"Mechanism of blebbistatin inhibition of myosin II","volume":"279","author":"Kov\u00e1cs","year":"2004","journal-title":"J Bio Chem"},{"key":"10.1016\/j.jacbts.2025.101449_bib39","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1529\/biophysj.108.137067","article-title":"Blebbistatin stabilizes the helical order of myosin filaments by promoting the switch 2 closed state","volume":"95","author":"Zhao","year":"2008","journal-title":"Biophys J"},{"issue":"8","key":"10.1016\/j.jacbts.2025.101449_bib40","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2314914121","article-title":"Myosin in autoinhibited off state(s), stabilized by mavacamten, can be recruited in response to inotropic interventions","volume":"121","author":"Ma","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.jacbts.2025.101449_bib41","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1001\/jamacardio.2022.5099","article-title":"Effects of mavacamten on measures of cardiopulmonary exercise testing beyond peak oxygen consumption","volume":"8","author":"Wheeler","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacbts.2025.101449_bib42","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.jacc.2020.03.064","article-title":"Evaluation of mavacamten in symptomatic patients with nonobstructive hypertrophic cardiomyopathy","volume":"75","author":"Ho","year":"2020","journal-title":"J Am Coll Cardiol"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X25004024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X25004024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:14:58Z","timestamp":1784232898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X25004024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2452302X25004024"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2025.101449","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myosin Modulator Aficamten Inhibits Force by Altering Myosin\u2019s Biochemical Activity Without Changing Thick Filament Structure","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2025.101449","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"101449"}}